廣汽(02238.HK):多家企業團隊駐企駐廠 閉環堅持生產研發
面對廣州當下疫情,廣汽集團(02238.HK)(601238.SH)表示,多家企業的團隊駐企駐廠,閉環堅持研發和生產。據統計,廣汽集團在番禺投資企業約3,800人、在從化明珠工業園投資企業約700人駐廠辦公和生產。
廣汽集團董事長曾慶洪一行近日赴廣汽研究院和廣汽乘用車時表示,在全力做好閉環生產經營的同時,各企業也積極保障員工身體健康與駐紮期間的生活,全力衝刺年度事業計劃目標的完成。
廣汽乘用車和廣汽研究院等自上周四(24日)起啟動閉環工作和生產演練,廣汽乘用車逾500名生產製造領域的員工,廣汽研究院296名研發設計人員和132名外協人員駐廠留守,全力以赴保產穩供。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.